An attractive proposal was made by examining 987 critically ill COVID-19 patients, finding that 101 of them had autoantibodies against interferons (IFN), suggesting that autoantibodies may neutralize IFN-mediated signalling [8]⁠. This evidence concerns the gene IFNA1 and COVID-19.